Development of an affinity silica monolith containing α1-acid glycoprotein for chiral separations

被引:57
|
作者
Mallik, Rangan [1 ]
Xuan, Hai [1 ]
Hage, David S. [1 ]
机构
[1] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA
关键词
affinity monolith; silica monolith; alpha(1)-acid glycoprotein; chiral separation; hydrazide method;
D O I
10.1016/j.chroma.2007.03.063
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An affinity monolith based on silica and containing immobilized alpha(1)-acid glycoprotein (AGP) was developed and evaluated in terms of its binding, efficiency and selectivity in chiral separations. The results were compared with data obtained for the same protein when used as a chiral stationary phase with HPLC-grade silica particles or monoliths based on a copolymer of glycidyl methacrylate (GMA) and ethylene dimethacrylate (EDMA). The surface coverage of AGP in the silica monolith was 18% higher than that obtained with silica particles and 61 % higher than that measured for a GMA/EDMA monolith. The higher surface area of the silica monolith gave materials that contained 1.5- to 3.6-times more immobilized protein per unit volume when compared to silica particles or a GMA/EDMA monolith. The retention, efficiency and resolving power of the AGP silica monolith were evaluated by injecting two chiral analytes onto this column (i.e., R/S-warfarin and R/S-propranolol). In each case, the AGP silica monolith gave higher retention plus better resolution and efficiency than AGP columns containing silica particles or a GMA/EDMA monolith. The AGP silica monolith also gave lower back pressures and separation impedances than these other materials. It was concluded that silica monoliths can be valuable alternatives to silica particles or GMA/EDMA monoliths when used with AGP as a chiral stationary phase. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:294 / 304
页数:11
相关论文
共 50 条
  • [1] Development of an affinity silica monolith containing human serum albumin for chiral separations
    Mallik, Rangan
    Hage, David S.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 46 (05) : 820 - 830
  • [2] Protein domain of chicken α1-acid glycoprotein is responsible for chiral recognition
    Sadakane, Y
    Matsunaga, H
    Nakagomi, K
    Hatanaka, Y
    Haginaka, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (03) : 587 - 590
  • [3] α1-acid glycoprotein in shock
    Muchitsch, EM
    Pichler, L
    Schwarz, HP
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R113 - R113
  • [4] α1-Acid glycoprotein affinity columns for the clean-up of adrenergic drugs
    Brambilla, G
    Fiori, M
    Curiel, I
    Serpe, L
    Gallo, P
    [J]. ANALYST, 1998, 123 (12) : 2693 - 2696
  • [5] Separation of the enantiomers of basic drugs by affinity capillary electrophoresis using a partial filling technique and α1-acid glycoprotein as chiral selectorglycoprotein as chiral selector
    Y. Tanaka
    S. Terabe
    [J]. Chromatographia, 1997, 44 : 119 - 128
  • [6] OPTIMIZATION OF CHIRAL SEPARATIONS ON SILICA-BONDED ALPHA-1-ACID GLYCOPROTEIN BY MOBILE PHASE ADDITIVES
    ARVIDSSON, E
    JANSSON, SO
    SCHILL, G
    [J]. ACS SYMPOSIUM SERIES, 1991, 471 : 126 - 140
  • [7] OPTIMIZATION OF CHIRAL SEPARATIONS ON SILICA-BONDED ALPHA-1-ACID GLYCOPROTEIN BY MOBILE PHASE ADDITIVES
    SCHILL, G
    ARVIDSSON, E
    BALMER, K
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 69 - ANYL
  • [8] New data on the sorption properties of α1-acid glycoprotein chiral stationary phase
    Gyimesi-Forrás, K
    Szász, G
    Budvári-Bárány, Z
    Gergely, A
    [J]. CHIRALITY, 1999, 11 (03) : 212 - 217
  • [9] Mechanistic aspects of chiral discrimination by surface-immobilized α1-acid glycoprotein
    Waters, MS
    Sidler, DR
    Simon, AJ
    Middaugh, CR
    Thompson, R
    August, LJ
    Bicker, G
    Perpall, HJ
    Grinberg, N
    [J]. CHIRALITY, 1999, 11 (03) : 224 - 232
  • [10] Contribution of the α1-Acid Glycoprotein in Drug Pharmacokinetics: The Usefulness of α1-Acid Glycoprotein-Knockout Mice
    Nakamura, Yuka
    Watanabe, Hiroshi
    Imafuku, Tadashi
    Fujita, Issei
    Ganaha, Yuto
    Takeo, Toru
    Nakagata, Naomi
    Maeda, Hitoshi
    Maruyama, Toru
    [J]. MOLECULAR PHARMACEUTICS, 2024, 21 (07) : 3144 - 3150